Cart
sales@molnova.com
c-Fms-IN-2
CAS No. 791587-67-2
c-Fms-IN-2( —— )
Catalog No. M26104 CAS No. 791587-67-2
c-Fms-IN-2 is an inhibitor of FMS kinase (IC50: 0.024 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 402 | Get Quote |
|
| 10MG | 593 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1251 | Get Quote |
|
| 100MG | 1692 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namec-Fms-IN-2
-
NoteResearch use only, not for human use.
-
Brief Descriptionc-Fms-IN-2 is an inhibitor of FMS kinase (IC50: 0.024 μM).
-
Descriptionc-Fms-IN-2 is an inhibitor of FMS kinase (IC50: 0.024 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
RecptorADC Linker| Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number791587-67-2
-
Formula Weight339.395
-
Molecular FormulaC19H21N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (294.65 mM)
-
SMILESCC1CCN(CC1)c1ccc(CO)cc1NC(=O)c1ccc(o1)C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Keith Alan Charlton, et al. Methods for the Treatment of an Infectious Bacterial Disease with an Anti-Lactone or Lactone Derived Signal Molecules Antibody. US20130045208A1
molnova catalog
related products
-
Axatilimab
Axatilimab (SNDX-6352) is a human IgG4 antibody targeting the colony-stimulating factor 1 receptor (CSF-1R), which can be used for the study of immune system disorders and respiratory diseases.
-
c-Fms-IN-13
c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50 = 17 nM) and serves as an anti-inflammatory agent.
-
Emactuzumab
Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM.
